Aristopharma Ltd

Our Products

Clobesol (Clobetasol)

Therapeutic Group : Skin care product

Share on facebook
Share on twitter
Share on print
Share on email
Clobesol has both local anti-inflammatory and immunosuppressive activity. The drug blocks the effect of macrophage migration inhibitory factor and decreases the activation of plasminogen to plasmin. Clobesol also reduces the number of human leukocyte antigen & also inhibits phospholipase A2 activity via formation of lipocortin. Clobetasol reduces the formation of prostaglandins and leucotrienes in the local tissues.